What is the Effect of Prolapse Surgery on Voiding?
PROVOID
1 other identifier
observational
453
1 country
1
Brief Summary
The aim of our study is to examine the effect of prolapse surgery on voiding. Our study is the very first one to combine several innovative low-invasive and low-cost methods to analyse the amelioration or deterioration of voiding function after surgery for pelvic organ prolapse using 3D/4D translabial ultrasound, home-uroflowmetry and patient reported quality of life outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2020
CompletedStudy Start
First participant enrolled
June 8, 2020
CompletedFirst Posted
Study publicly available on registry
June 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 8, 2023
CompletedJune 12, 2020
June 1, 2020
2 years
April 30, 2020
June 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in lower urinary tract symptoms pre- postoperatively
Voiding diary
1 year follow-up
Change in lower urinary tract symptoms pre- postoperatively
Questionnaire: PFDI-20
1 year follow-up
Secondary Outcomes (5)
Change in clinical outcome measures
1 year follow-up
Change in clinical outcome measures
1 year follow-up
Change in voiding
1 year follow-up
Change in QoL
1 year follow-up
Change in QoL
1 year follow-up
Interventions
Pelvic reconstructive surgery
Eligibility Criteria
Women attending a gynecological unit with symptoms of pelvic organ prolapse and who will undergo pelvic floor surgery as management of their symptoms.
You may qualify if:
- age ≥18 years
- Dutch, French or English- speaking women
- symptoms of pelvic organ prolapse
- preoperatively pelvic floor surgery.
You may not qualify if:
- \- history of neurological disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Antwerp
Edegem, Antwerp, 2650, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Department Gynecology, UZA
Study Record Dates
First Submitted
April 30, 2020
First Posted
June 12, 2020
Study Start
June 8, 2020
Primary Completion
June 8, 2022
Study Completion
June 8, 2023
Last Updated
June 12, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share